-
1
-
-
47249137598
-
-
Health and Welfare Statistics Association:, in Japanese
-
Health and Welfare Statistics Association: J Health and Welfare Statistics, 1999; 46:410-411 (in Japanese)
-
(1999)
J Health and Welfare Statistics
, vol.46
, pp. 410-411
-
-
-
2
-
-
0021699819
-
Ischemic heart disease risk factors after age 50
-
Barrett-Connor E, Suarez L, Khaw KT, Criqui MH, and Wiugard DL: Ischemic heart disease risk factors after age 50. J Chron Dis, 1984; 37:903-908
-
(1984)
J Chron Dis
, vol.37
, pp. 903-908
-
-
Barrett-Connor, E.1
Suarez, L.2
Khaw, K.T.3
Criqui, M.H.4
Wiugard, D.L.5
-
3
-
-
0024110609
-
Proportional hazards analysis of risk factors for coronary heart disease in individuals aged 65 or older. The Framingham Heart Study: The Framingham Heart Study
-
Harris T, Cook EF, Kannel WB, and Goldman L: Proportional hazards analysis of risk factors for coronary heart disease in individuals aged 65 or older. The Framingham Heart Study: The Framingham Heart Study. J Am Geriatr Soc, 1988; 36:1023-1028
-
(1988)
J Am Geriatr Soc
, vol.36
, pp. 1023-1028
-
-
Harris, T.1
Cook, E.F.2
Kannel, W.B.3
Goldman, L.4
-
4
-
-
0025695497
-
High blood cholesterol in elderly men and the excess risk for coronary heart disease
-
Rubin SM, Sidney S, Black DM, Browner WS, Hulley SB, and Cummings SR: High blood cholesterol in elderly men and the excess risk for coronary heart disease. Ann Inter Med, 1990; 113:916-920
-
(1990)
Ann Inter Med
, vol.113
, pp. 916-920
-
-
Rubin, S.M.1
Sidney, S.2
Black, D.M.3
Browner, W.S.4
Hulley, S.B.5
Cummings, S.R.6
-
5
-
-
0025504621
-
The relation of serum cholesterol to risk of coronary heart disease: Implications for the elderly
-
Pacala JT: The relation of serum cholesterol to risk of coronary heart disease: implications for the elderly. J Am Board Fam Pract, 1990; 3:271-282
-
(1990)
J Am Board Fam Pract
, vol.3
, pp. 271-282
-
-
Pacala, J.T.1
-
6
-
-
0025019678
-
Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly?
-
Benfante R and Reed D: Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly? JAMA, 1990; 263:393-396
-
(1990)
JAMA
, vol.263
, pp. 393-396
-
-
Benfante, R.1
Reed, D.2
-
7
-
-
0030967498
-
Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons
-
Corti MC, Guralnik JM, Salive ME, Harris T, Ferrucci L, Glynn RJ, and Havlik RJ: Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med, 1997; 126:753-760
-
(1997)
Ann Intern Med
, vol.126
, pp. 753-760
-
-
Corti, M.C.1
Guralnik, J.M.2
Salive, M.E.3
Harris, T.4
Ferrucci, L.5
Glynn, R.J.6
Havlik, R.J.7
-
8
-
-
85036902254
-
Nousocchunadoniyorunetakiri, shibouno-kenkoukikendohyoukasisutemukaihatsugigyou
-
The Japanese Association for Cerebro-cardiovascular Disease Control:, in Japanese
-
The Japanese Association for Cerebro-cardiovascular Disease Control: Nousocchunadoniyorunetakiri, shibouno-kenkoukikendohyoukasisutemukaihatsugigyou. 1980nenjunkakisikkankisochousatuisekichousahoukoku, 1995 (in Japanese)
-
(1995)
1980nenjunkakisikkankisochousatuisekichousahoukoku
-
-
-
9
-
-
0027167905
-
Total serum cholesterol levels and mortality risk as a function of age. A report based on the Framingham data
-
Kronmal RA, Cain KC, Ye Z, and Omenn GS: Total serum cholesterol levels and mortality risk as a function of age. A report based on the Framingham data. Arch Intern Med, 1993; 153:1065-1073
-
(1993)
Arch Intern Med
, vol.153
, pp. 1065-1073
-
-
Kronmal, R.A.1
Cain, K.C.2
Ye, Z.3
Omenn, G.S.4
-
10
-
-
84942385641
-
Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years
-
Kumholz HM, Seeman TE, Merrill SS, Mendes de Leon CF, Vaccarino V, Silverman DI, Tsukahara R, Ostfeld AM, and Berkmam LF: Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years. JAMA, 1994; 272:1335-1340
-
(1994)
JAMA
, vol.272
, pp. 1335-1340
-
-
Kumholz, H.M.1
Seeman, T.E.2
Merrill, S.S.3
Mendes de Leon, C.F.4
Vaccarino, V.5
Silverman, D.I.6
Tsukahara, R.7
Ostfeld, A.M.8
Berkmam, L.F.9
-
11
-
-
0030699431
-
Total cholesterol and risk of mortality in the oldest old
-
Weverling-Rijnsburger AW, Blauw GJ, Lagaay AM, Knook DL, Meinders AE, and Westendorp RG: Total cholesterol and risk of mortality in the oldest old. Lancet, 1997; 350:1119-1123
-
(1997)
Lancet
, vol.350
, pp. 1119-1123
-
-
Weverling-Rijnsburger, A.W.1
Blauw, G.J.2
Lagaay, A.M.3
Knook, D.L.4
Meinders, A.E.5
Westendorp, R.G.6
-
12
-
-
0024519925
-
Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial
-
Iso H, Jacobs DR Jr., Wentworth D, Neaton JD, and Cohen JD: Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med, 1989; 320:904-910
-
(1989)
N Engl J Med
, vol.320
, pp. 904-910
-
-
Iso, H.1
Jacobs Jr., D.R.2
Wentworth, D.3
Neaton, J.D.4
Cohen, J.D.5
-
13
-
-
0027380992
-
Cholesterol reduction and the risk for stroke in men. A meta-analysis of randomized, controlled trials
-
Atkins D, Psaty BM, Koepsell TD, Longstreth WT Jr., and Larson EB: Cholesterol reduction and the risk for stroke in men. A meta-analysis of randomized, controlled trials. Ann Intern Med, 1993; 119:136-145
-
(1993)
Ann Intern Med
, vol.119
, pp. 136-145
-
-
Atkins, D.1
Psaty, B.M.2
Koepsell, T.D.3
Longstreth Jr., W.T.4
Larson, E.B.5
-
14
-
-
0343273397
-
Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration
-
Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration. Lancet, 1995; 346:8991-8992
-
(1995)
Lancet
, vol.346
, pp. 8991-8992
-
-
-
15
-
-
0036272985
-
Changes in serum lipid levels during a 10 year period in a large Japanese population. A cross-sectional and longitudinal study
-
Kuzuya M, Ando F, Iguchi A, and Shimokata H: Changes in serum lipid levels during a 10 year period in a large Japanese population. A cross-sectional and longitudinal study. Atherosclerosis, 2002; 163:313-320
-
(2002)
Atherosclerosis
, vol.163
, pp. 313-320
-
-
Kuzuya, M.1
Ando, F.2
Iguchi, A.3
Shimokata, H.4
-
16
-
-
0344653659
-
Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: Findings from the Scandinavian Simvastatin Survival Study (4S)
-
Miettinen TA, Pyörälä K, Olsson AG, Musliner TA, Cook TJ, Faergeman O, Berg K, Pedersen T, and Kjekshus J: Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: Findings from the Scandinavian Simvastatin Survival Study (4S). Circulation, 1997; 96:4211-4218
-
(1997)
Circulation
, vol.96
, pp. 4211-4218
-
-
Miettinen, T.A.1
Pyörälä, K.2
Olsson, A.G.3
Musliner, T.A.4
Cook, T.J.5
Faergeman, O.6
Berg, K.7
Pedersen, T.8
Kjekshus, J.9
-
17
-
-
14444271787
-
Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range: Results of the Cholesterol and Recurrent Events (CARE) trial
-
Lewis SJ, Moye LA, Sacks FM, Jhnstone DE, Timmis G, Mitchell J, Limacher M, Kell S, Glasser SP, Grant J, Davis BR, Pfeffer MA, and Braunwald E: Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range: Results of the Cholesterol and Recurrent Events (CARE) trial. Ann Intern Med, 1998; 129:681-689
-
(1998)
Ann Intern Med
, vol.129
, pp. 681-689
-
-
Lewis, S.J.1
Moye, L.A.2
Sacks, F.M.3
Jhnstone, D.E.4
Timmis, G.5
Mitchell, J.6
Limacher, M.7
Kell, S.8
Glasser, S.P.9
Grant, J.10
Davis, B.R.11
Pfeffer, M.A.12
Braunwald, E.13
-
18
-
-
0037031061
-
-
Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet, 2002; 360:7-22
-
Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet, 2002; 360:7-22
-
-
-
-
19
-
-
0037420492
-
ASCOT investigators: Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
-
Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, and Ostergren J; ASCOT investigators: Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet, 2003; 361:1149-1158
-
(2003)
Lancet
, vol.361
, pp. 1149-1158
-
-
Sever, P.S.1
Dahlöf, B.2
Poulter, N.R.3
Wedel, H.4
Beevers, G.5
Caulfield, M.6
Collins, R.7
Kjeldsen, S.E.8
Kristinsson, A.9
McInnes, G.T.10
Mehlsen, J.11
Nieminen, M.12
O'Brien, E.13
Ostergren, J.14
-
20
-
-
0028883828
-
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
-
Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, and Packard CJ: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med, 1995; 333:1301-1307
-
(1995)
West of Scotland Coronary Prevention Study Group. N Engl J Med
, vol.333
, pp. 1301-1307
-
-
Shepherd, J.1
Cobbe, S.M.2
Ford, I.3
Isles, C.G.4
Lorimer, A.R.5
MacFarlane, P.W.6
McKillop, J.H.7
Packard, C.J.8
-
21
-
-
0342981862
-
The effect of pravastatin on coronary events after myocardial infarction inpatients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators
-
Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, Davis BR, and Braunwald E: The effect of pravastatin on coronary events after myocardial infarction inpatients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med, 1996; 335:1001-1009
-
(1996)
N Engl J Med
, vol.335
, pp. 1001-1009
-
-
Sacks, F.M.1
Pfeffer, M.A.2
Moye, L.A.3
Rouleau, J.L.4
Rutherford, J.D.5
Cole, T.G.6
Brown, L.7
Warnica, J.W.8
Arnold, J.M.9
Wun, C.C.10
Davis, B.R.11
Braunwald, E.12
-
22
-
-
0032487931
-
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
-
The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
-
The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group: Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med, 1998; 339:1349-1357
-
(1998)
N Engl J Med
, vol.339
, pp. 1349-1357
-
-
-
23
-
-
0034680352
-
Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: The Prospective Pravastatin Pooling Project
-
Sacks FM, Tonkin AM, Shepherd J, Braunwald E, Cobbe S, Hawkins CM, Keech A, Packard C, Simes J, Byington R, and Furberg CD: Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: The Prospective Pravastatin Pooling Project. Circulation, 2000; 102:1893-1900
-
(2000)
Circulation
, vol.102
, pp. 1893-1900
-
-
Sacks, F.M.1
Tonkin, A.M.2
Shepherd, J.3
Braunwald, E.4
Cobbe, S.5
Hawkins, C.M.6
Keech, A.7
Packard, C.8
Simes, J.9
Byington, R.10
Furberg, C.D.11
-
24
-
-
0037164314
-
PROSPER study group. PROspective Study of Pravastatin in the Elderly at Risk: Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
-
Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Meinders AE, Norrie J, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, and Westendorp RG; PROSPER study group. PROspective Study of Pravastatin in the Elderly at Risk: Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet, 2002; 360:1623-1630
-
(2002)
Lancet
, vol.360
, pp. 1623-1630
-
-
Shepherd, J.1
Blauw, G.J.2
Murphy, M.B.3
Bollen, E.L.4
Buckley, B.M.5
Cobbe, S.M.6
Ford, I.7
Gaw, A.8
Hyland, M.9
Jukema, J.W.10
Kamper, A.M.11
Macfarlane, P.W.12
Meinders, A.E.13
Norrie, J.14
Packard, C.J.15
Perry, I.J.16
Stott, D.J.17
Sweeney, B.J.18
Twomey, C.19
Westendorp, R.G.20
more..
-
25
-
-
0035233631
-
A comparison of low versus standard dose pravastatin therapy for the prevention of cardiovascular events in the elderly: The pravastatin anti-atherosclerosis trial in the elderly (PATE)
-
Ito H, Ouchi Y, Ohashi Y, Saito Y, Ishikawa T, Nakamura H, and Orimo H; A comparison of low versus standard dose pravastatin therapy for the prevention of cardiovascular events in the elderly: the pravastatin anti-atherosclerosis trial in the elderly (PATE). J Atheroscler Thromb, 2001; 8:33-44
-
(2001)
J Atheroscler Thromb
, vol.8
, pp. 33-44
-
-
Ito, H.1
Ouchi, Y.2
Ohashi, Y.3
Saito, Y.4
Ishikawa, T.5
Nakamura, H.6
Orimo, H.7
-
26
-
-
33748952489
-
MEGA Study Group: Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomized controlled trial
-
Nakamura H, Arakawa K, Itakura H, Kitabatake A, Goto Y, Toyota T, Nakaya N, Nishimoto S, Muranaka M, Yamamoto A, Mizuno K, and Ohashi Y; MEGA Study Group: Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomized controlled trial. Lancet, 2006; 368:1155-1163
-
(2006)
Lancet
, vol.368
, pp. 1155-1163
-
-
Nakamura, H.1
Arakawa, K.2
Itakura, H.3
Kitabatake, A.4
Goto, Y.5
Toyota, T.6
Nakaya, N.7
Nishimoto, S.8
Muranaka, M.9
Yamamoto, A.10
Mizuno, K.11
Ohashi, Y.12
-
27
-
-
34547690320
-
MEGA Study Group: Vascular Disease, Hypertension and Prevention: Marked risk reduction in coronary heart disease, stroke and total mortality in women ≧ 60 years old with low-dose pravastatin for primary prevention in the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study
-
Mizuno K, Nakamura H, MEGA Study Group: Vascular Disease, Hypertension and Prevention: Marked risk reduction in coronary heart disease, stroke and total mortality in women ≧ 60 years old with low-dose pravastatin for primary prevention in the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study. J Am Coll Cardiol, 2006; 47(Suppl 1):A354
-
(2006)
J Am Coll Cardiol
, vol.47
, Issue.SUPPL. 1
-
-
Mizuno, K.1
Nakamura, H.2
-
28
-
-
2442657587
-
Kyushu Lipid Intervention Study (KLIS) Group: Relation of serum total cholesterol and other factors to risk of coronary events in middle-aged and elderly Japanese men with hypercholesterolemia: the Kyushu Lipid Intervention study
-
Iwashita M, Matsushita Y, Sasaki J, Arakawa K, and Kono S; Kyushu Lipid Intervention Study (KLIS) Group: Relation of serum total cholesterol and other factors to risk of coronary events in middle-aged and elderly Japanese men with hypercholesterolemia: the Kyushu Lipid Intervention study. Circ J, 2004; 68:405-409
-
(2004)
Circ J
, vol.68
, pp. 405-409
-
-
Iwashita, M.1
Matsushita, Y.2
Sasaki, J.3
Arakawa, K.4
Kono, S.5
-
29
-
-
16644382228
-
J-LIT Study Group: Primary cardiovascular events and serum lipid levels in elderly Japanese with hypercholesterolemia undergoing 6-year simvastatin treatment: A subanalysis of the Japan lipid intervention trial
-
Horiuchi H, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, and Itakura H; J-LIT Study Group: Primary cardiovascular events and serum lipid levels in elderly Japanese with hypercholesterolemia undergoing 6-year simvastatin treatment: A subanalysis of the Japan lipid intervention trial. J Am Geriatr Soc, 2004; 52:1981-1987
-
(2004)
J Am Geriatr Soc
, vol.52
, pp. 1981-1987
-
-
Horiuchi, H.1
Kita, T.2
Mabuchi, H.3
Matsuzaki, M.4
Matsuzawa, Y.5
Nakaya, N.6
Oikawa, S.7
Saito, Y.8
Sasaki, J.9
Shimamoto, K.10
Itakura, H.11
-
30
-
-
0034006160
-
Efficacy of cholesterol-lowering treatment in Japanese elderly patients with coronary artery disease and normal cholesterol level using 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor
-
Chikamori T, Sugimoto K, Hamada T, Kitaoka H, Furuno T, Seo H, and Doi Y: Efficacy of cholesterol-lowering treatment in Japanese elderly patients with coronary artery disease and normal cholesterol level using 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. J Cardiol, 2000; 35:95-101
-
(2000)
J Cardiol
, vol.35
, pp. 95-101
-
-
Chikamori, T.1
Sugimoto, K.2
Hamada, T.3
Kitaoka, H.4
Furuno, T.5
Seo, H.6
Doi, Y.7
-
31
-
-
0035936503
-
Reduction of stroke events with pravastatin: The Prospective Pravastatin Pooling (PPP) Project
-
Byington RP, Davis BR, Plehn JF, White HD, Baker J, Cobbe SM, and Shepherd J: Reduction of stroke events with pravastatin: the Prospective Pravastatin Pooling (PPP) Project. Circulation, 2001; 103:387-392
-
(2001)
Circulation
, vol.103
, pp. 387-392
-
-
Byington, R.P.1
Davis, B.R.2
Plehn, J.F.3
White, H.D.4
Baker, J.5
Cobbe, S.M.6
Shepherd, J.7
-
32
-
-
12344313935
-
Kyushu Lipid Intervention Study (KLIS) Group: Relation of serum total cholesterol and other factors to risk of cerebral infarction in Japanese men with hypercholesterolemia
-
Iwashita M, Matsushira Y, Sasaki J, Arakawa K, and Kono S; Kyushu Lipid Intervention Study (KLIS) Group: Relation of serum total cholesterol and other factors to risk of cerebral infarction in Japanese men with hypercholesterolemia. Circ J, 2005; 69:1-6
-
(2005)
Circ J
, vol.69
, pp. 1-6
-
-
Iwashita, M.1
Matsushira, Y.2
Sasaki, J.3
Arakawa, K.4
Kono, S.5
-
33
-
-
27744572249
-
J-LIT Study Group: Large-scale cohort study on the relationship between serum lipid concentrations and risk of cerebrovascular disease under low-dose simvastatin in Japanese patients with hypercholesterolemia: sub-analysis of the Japan Lipid Intervention Trial (J-LIT)
-
Nakaya N, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Oikawa S, Saito Y, Sasaki J, Shimamoto K, and Itakura H; J-LIT Study Group: Large-scale cohort study on the relationship between serum lipid concentrations and risk of cerebrovascular disease under low-dose simvastatin in Japanese patients with hypercholesterolemia: sub-analysis of the Japan Lipid Intervention Trial (J-LIT). Circ J, 2005; 69:1016-1021
-
(2005)
Circ J
, vol.69
, pp. 1016-1021
-
-
Nakaya, N.1
Kita, T.2
Mabuchi, H.3
Matsuzaki, M.4
Matsuzawa, Y.5
Oikawa, S.6
Saito, Y.7
Sasaki, J.8
Shimamoto, K.9
Itakura, H.10
|